HIGHLY CONCENTRATED LOW VISCOSITY MASP-2 INHIBITORY ANTIBODY FORMULATIONS, KITS, AND METHODS
The present invention relates to stable, high-concentration low-viscosity formulations of MASP-2 inhibitory antibodies, kits comprising the formulations and therapeutic methods using the formulations and kits for inhibiting the adverse effects of MASP-2 dependent complement activation.
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; srp |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WHITAKER, JOHN STEVEN DEMOPULOS, GREGORY A LAMBERT, WILLIAM JOSEPH FERGUSON, KENNETH M |
| description | The present invention relates to stable, high-concentration low-viscosity formulations of MASP-2 inhibitory antibodies, kits comprising the formulations and therapeutic methods using the formulations and kits for inhibiting the adverse effects of MASP-2 dependent complement activation. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_RS65845B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>RS65845B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_RS65845B13</originalsourceid><addsrcrecordid>eNqFyr0KwjAUQOEsDqK-gtwHsIM_Fdc0Sc3FJleSqxIQSpE4iRbq-6ODu8v5ljMWV4t72yRQ5JXxHCQbDQ1d4IxRUURO4GQ8FitAb7FCppBAesaKdIKagjs1kpF8XMAB-VvpNTjDlnScitG9ewx59nMi5rVhZYvcv9o89N0tP_O7DXFb7jZltVz_HT68tDGH</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HIGHLY CONCENTRATED LOW VISCOSITY MASP-2 INHIBITORY ANTIBODY FORMULATIONS, KITS, AND METHODS</title><source>esp@cenet</source><creator>WHITAKER, JOHN STEVEN ; DEMOPULOS, GREGORY A ; LAMBERT, WILLIAM JOSEPH ; FERGUSON, KENNETH M</creator><creatorcontrib>WHITAKER, JOHN STEVEN ; DEMOPULOS, GREGORY A ; LAMBERT, WILLIAM JOSEPH ; FERGUSON, KENNETH M</creatorcontrib><description>The present invention relates to stable, high-concentration low-viscosity formulations of MASP-2 inhibitory antibodies, kits comprising the formulations and therapeutic methods using the formulations and kits for inhibiting the adverse effects of MASP-2 dependent complement activation.</description><language>eng ; srp</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2024</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240930&DB=EPODOC&CC=RS&NR=65845B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76419</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20240930&DB=EPODOC&CC=RS&NR=65845B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WHITAKER, JOHN STEVEN</creatorcontrib><creatorcontrib>DEMOPULOS, GREGORY A</creatorcontrib><creatorcontrib>LAMBERT, WILLIAM JOSEPH</creatorcontrib><creatorcontrib>FERGUSON, KENNETH M</creatorcontrib><title>HIGHLY CONCENTRATED LOW VISCOSITY MASP-2 INHIBITORY ANTIBODY FORMULATIONS, KITS, AND METHODS</title><description>The present invention relates to stable, high-concentration low-viscosity formulations of MASP-2 inhibitory antibodies, kits comprising the formulations and therapeutic methods using the formulations and kits for inhibiting the adverse effects of MASP-2 dependent complement activation.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2024</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqFyr0KwjAUQOEsDqK-gtwHsIM_Fdc0Sc3FJleSqxIQSpE4iRbq-6ODu8v5ljMWV4t72yRQ5JXxHCQbDQ1d4IxRUURO4GQ8FitAb7FCppBAesaKdIKagjs1kpF8XMAB-VvpNTjDlnScitG9ewx59nMi5rVhZYvcv9o89N0tP_O7DXFb7jZltVz_HT68tDGH</recordid><startdate>20240930</startdate><enddate>20240930</enddate><creator>WHITAKER, JOHN STEVEN</creator><creator>DEMOPULOS, GREGORY A</creator><creator>LAMBERT, WILLIAM JOSEPH</creator><creator>FERGUSON, KENNETH M</creator><scope>EVB</scope></search><sort><creationdate>20240930</creationdate><title>HIGHLY CONCENTRATED LOW VISCOSITY MASP-2 INHIBITORY ANTIBODY FORMULATIONS, KITS, AND METHODS</title><author>WHITAKER, JOHN STEVEN ; DEMOPULOS, GREGORY A ; LAMBERT, WILLIAM JOSEPH ; FERGUSON, KENNETH M</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_RS65845B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; srp</language><creationdate>2024</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>WHITAKER, JOHN STEVEN</creatorcontrib><creatorcontrib>DEMOPULOS, GREGORY A</creatorcontrib><creatorcontrib>LAMBERT, WILLIAM JOSEPH</creatorcontrib><creatorcontrib>FERGUSON, KENNETH M</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WHITAKER, JOHN STEVEN</au><au>DEMOPULOS, GREGORY A</au><au>LAMBERT, WILLIAM JOSEPH</au><au>FERGUSON, KENNETH M</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HIGHLY CONCENTRATED LOW VISCOSITY MASP-2 INHIBITORY ANTIBODY FORMULATIONS, KITS, AND METHODS</title><date>2024-09-30</date><risdate>2024</risdate><abstract>The present invention relates to stable, high-concentration low-viscosity formulations of MASP-2 inhibitory antibodies, kits comprising the formulations and therapeutic methods using the formulations and kits for inhibiting the adverse effects of MASP-2 dependent complement activation.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; srp |
| recordid | cdi_epo_espacenet_RS65845B1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | HIGHLY CONCENTRATED LOW VISCOSITY MASP-2 INHIBITORY ANTIBODY FORMULATIONS, KITS, AND METHODS |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T20%3A20%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WHITAKER,%20JOHN%20STEVEN&rft.date=2024-09-30&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ERS65845B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |